Targeting transcription factor STAT3 for cancer prevention and therapy

Signal Transducers and Activators of Transcription (STATs) comprise an important class of transcription factors that have been implicated in a wide variety of essential cellular functions related to proliferation, survival, and angiogenesis. Among various STAT members, STAT3 is frequently overexpres...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pharmacology & therapeutics (Oxford) 2016-06, Vol.162, p.86-97
Hauptverfasser: Chai, Edna Zhi Pei, Shanmugam, Muthu K, Arfuso, Frank, Dharmarajan, Arunasalam, Wang, Chao, Kumar, Alan Prem, Samy, Ramar Perumal, Lim, Lina H K, Wang, Lingzhi, Goh, Boon Cher, Ahn, Kwang Seok, Hui, Kam Man, Sethi, Gautam
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 97
container_issue
container_start_page 86
container_title Pharmacology & therapeutics (Oxford)
container_volume 162
creator Chai, Edna Zhi Pei
Shanmugam, Muthu K
Arfuso, Frank
Dharmarajan, Arunasalam
Wang, Chao
Kumar, Alan Prem
Samy, Ramar Perumal
Lim, Lina H K
Wang, Lingzhi
Goh, Boon Cher
Ahn, Kwang Seok
Hui, Kam Man
Sethi, Gautam
description Signal Transducers and Activators of Transcription (STATs) comprise an important class of transcription factors that have been implicated in a wide variety of essential cellular functions related to proliferation, survival, and angiogenesis. Among various STAT members, STAT3 is frequently overexpressed in tumor cells as well as tissue samples, and regulates the expression of numerous oncogenic genes controlling the growth and metastasis of tumor cells. The current review briefly discusses the importance of STAT3 as a potential target for cancer therapy and also provides novel insights into various classes of existing pharmacological inhibitors of this transcription factor that can be potentially developed as anti-cancer drugs.
doi_str_mv 10.1016/j.pharmthera.2015.10.004
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1793216340</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1793216340</sourcerecordid><originalsourceid>FETCH-LOGICAL-c315t-f362dbf3a8cf72fd3ac1d3b336b0b6def28b34796dd593b6b62c96ed332ba27f3</originalsourceid><addsrcrecordid>eNpFkMtOwzAQRS0EoqXwCyhLNgm2J3GSZVVRQKrEgiCxs_xsUzUP7BSpf4_TFliN5TnXMz4IRQQnBBP2uE36jXDNsDFOJBSTLFwnGKcXaEqKvIwD83mJpqFAnNOsmKAb77c4ECmm12hCWZoXaUqmaFkJtzZD3a6jwYnWK1f3Q921kRVq6Fz0Xs0riGw4KdEq46LemW_THhHR6ui4Qn-4RVdW7Ly5O9cZ-lg-VYuXePX2_LqYr2IFJBtiC4xqaUEUyubUahCKaJAATGLJtLG0kJDmJdM6K0EyyagqmdEAVAqaW5ihh9O7veu-9sYPvKm9MrudaE2395zkJdDw6xQHtDihynXeO2N57-pGuAMnmI8W-Zb_W-SjxbETHIXo_XnKXjZG_wV_tcEPjtZyrg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1793216340</pqid></control><display><type>article</type><title>Targeting transcription factor STAT3 for cancer prevention and therapy</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Chai, Edna Zhi Pei ; Shanmugam, Muthu K ; Arfuso, Frank ; Dharmarajan, Arunasalam ; Wang, Chao ; Kumar, Alan Prem ; Samy, Ramar Perumal ; Lim, Lina H K ; Wang, Lingzhi ; Goh, Boon Cher ; Ahn, Kwang Seok ; Hui, Kam Man ; Sethi, Gautam</creator><creatorcontrib>Chai, Edna Zhi Pei ; Shanmugam, Muthu K ; Arfuso, Frank ; Dharmarajan, Arunasalam ; Wang, Chao ; Kumar, Alan Prem ; Samy, Ramar Perumal ; Lim, Lina H K ; Wang, Lingzhi ; Goh, Boon Cher ; Ahn, Kwang Seok ; Hui, Kam Man ; Sethi, Gautam</creatorcontrib><description>Signal Transducers and Activators of Transcription (STATs) comprise an important class of transcription factors that have been implicated in a wide variety of essential cellular functions related to proliferation, survival, and angiogenesis. Among various STAT members, STAT3 is frequently overexpressed in tumor cells as well as tissue samples, and regulates the expression of numerous oncogenic genes controlling the growth and metastasis of tumor cells. The current review briefly discusses the importance of STAT3 as a potential target for cancer therapy and also provides novel insights into various classes of existing pharmacological inhibitors of this transcription factor that can be potentially developed as anti-cancer drugs.</description><identifier>ISSN: 0163-7258</identifier><identifier>EISSN: 1879-016X</identifier><identifier>DOI: 10.1016/j.pharmthera.2015.10.004</identifier><identifier>PMID: 26478441</identifier><language>eng</language><publisher>England</publisher><subject>Animals ; Antineoplastic Agents - pharmacology ; Antineoplastic Agents - therapeutic use ; Carcinogenesis - metabolism ; Humans ; Neoplasms - drug therapy ; Neoplasms - metabolism ; Neoplasms - prevention &amp; control ; Signal Transduction ; STAT3 Transcription Factor - antagonists &amp; inhibitors ; STAT3 Transcription Factor - metabolism</subject><ispartof>Pharmacology &amp; therapeutics (Oxford), 2016-06, Vol.162, p.86-97</ispartof><rights>Copyright © 2015 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c315t-f362dbf3a8cf72fd3ac1d3b336b0b6def28b34796dd593b6b62c96ed332ba27f3</citedby><cites>FETCH-LOGICAL-c315t-f362dbf3a8cf72fd3ac1d3b336b0b6def28b34796dd593b6b62c96ed332ba27f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26478441$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chai, Edna Zhi Pei</creatorcontrib><creatorcontrib>Shanmugam, Muthu K</creatorcontrib><creatorcontrib>Arfuso, Frank</creatorcontrib><creatorcontrib>Dharmarajan, Arunasalam</creatorcontrib><creatorcontrib>Wang, Chao</creatorcontrib><creatorcontrib>Kumar, Alan Prem</creatorcontrib><creatorcontrib>Samy, Ramar Perumal</creatorcontrib><creatorcontrib>Lim, Lina H K</creatorcontrib><creatorcontrib>Wang, Lingzhi</creatorcontrib><creatorcontrib>Goh, Boon Cher</creatorcontrib><creatorcontrib>Ahn, Kwang Seok</creatorcontrib><creatorcontrib>Hui, Kam Man</creatorcontrib><creatorcontrib>Sethi, Gautam</creatorcontrib><title>Targeting transcription factor STAT3 for cancer prevention and therapy</title><title>Pharmacology &amp; therapeutics (Oxford)</title><addtitle>Pharmacol Ther</addtitle><description>Signal Transducers and Activators of Transcription (STATs) comprise an important class of transcription factors that have been implicated in a wide variety of essential cellular functions related to proliferation, survival, and angiogenesis. Among various STAT members, STAT3 is frequently overexpressed in tumor cells as well as tissue samples, and regulates the expression of numerous oncogenic genes controlling the growth and metastasis of tumor cells. The current review briefly discusses the importance of STAT3 as a potential target for cancer therapy and also provides novel insights into various classes of existing pharmacological inhibitors of this transcription factor that can be potentially developed as anti-cancer drugs.</description><subject>Animals</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>Antineoplastic Agents - therapeutic use</subject><subject>Carcinogenesis - metabolism</subject><subject>Humans</subject><subject>Neoplasms - drug therapy</subject><subject>Neoplasms - metabolism</subject><subject>Neoplasms - prevention &amp; control</subject><subject>Signal Transduction</subject><subject>STAT3 Transcription Factor - antagonists &amp; inhibitors</subject><subject>STAT3 Transcription Factor - metabolism</subject><issn>0163-7258</issn><issn>1879-016X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkMtOwzAQRS0EoqXwCyhLNgm2J3GSZVVRQKrEgiCxs_xsUzUP7BSpf4_TFliN5TnXMz4IRQQnBBP2uE36jXDNsDFOJBSTLFwnGKcXaEqKvIwD83mJpqFAnNOsmKAb77c4ECmm12hCWZoXaUqmaFkJtzZD3a6jwYnWK1f3Q921kRVq6Fz0Xs0riGw4KdEq46LemW_THhHR6ui4Qn-4RVdW7Ly5O9cZ-lg-VYuXePX2_LqYr2IFJBtiC4xqaUEUyubUahCKaJAATGLJtLG0kJDmJdM6K0EyyagqmdEAVAqaW5ihh9O7veu-9sYPvKm9MrudaE2395zkJdDw6xQHtDihynXeO2N57-pGuAMnmI8W-Zb_W-SjxbETHIXo_XnKXjZG_wV_tcEPjtZyrg</recordid><startdate>201606</startdate><enddate>201606</enddate><creator>Chai, Edna Zhi Pei</creator><creator>Shanmugam, Muthu K</creator><creator>Arfuso, Frank</creator><creator>Dharmarajan, Arunasalam</creator><creator>Wang, Chao</creator><creator>Kumar, Alan Prem</creator><creator>Samy, Ramar Perumal</creator><creator>Lim, Lina H K</creator><creator>Wang, Lingzhi</creator><creator>Goh, Boon Cher</creator><creator>Ahn, Kwang Seok</creator><creator>Hui, Kam Man</creator><creator>Sethi, Gautam</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201606</creationdate><title>Targeting transcription factor STAT3 for cancer prevention and therapy</title><author>Chai, Edna Zhi Pei ; Shanmugam, Muthu K ; Arfuso, Frank ; Dharmarajan, Arunasalam ; Wang, Chao ; Kumar, Alan Prem ; Samy, Ramar Perumal ; Lim, Lina H K ; Wang, Lingzhi ; Goh, Boon Cher ; Ahn, Kwang Seok ; Hui, Kam Man ; Sethi, Gautam</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c315t-f362dbf3a8cf72fd3ac1d3b336b0b6def28b34796dd593b6b62c96ed332ba27f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Animals</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>Antineoplastic Agents - therapeutic use</topic><topic>Carcinogenesis - metabolism</topic><topic>Humans</topic><topic>Neoplasms - drug therapy</topic><topic>Neoplasms - metabolism</topic><topic>Neoplasms - prevention &amp; control</topic><topic>Signal Transduction</topic><topic>STAT3 Transcription Factor - antagonists &amp; inhibitors</topic><topic>STAT3 Transcription Factor - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chai, Edna Zhi Pei</creatorcontrib><creatorcontrib>Shanmugam, Muthu K</creatorcontrib><creatorcontrib>Arfuso, Frank</creatorcontrib><creatorcontrib>Dharmarajan, Arunasalam</creatorcontrib><creatorcontrib>Wang, Chao</creatorcontrib><creatorcontrib>Kumar, Alan Prem</creatorcontrib><creatorcontrib>Samy, Ramar Perumal</creatorcontrib><creatorcontrib>Lim, Lina H K</creatorcontrib><creatorcontrib>Wang, Lingzhi</creatorcontrib><creatorcontrib>Goh, Boon Cher</creatorcontrib><creatorcontrib>Ahn, Kwang Seok</creatorcontrib><creatorcontrib>Hui, Kam Man</creatorcontrib><creatorcontrib>Sethi, Gautam</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Pharmacology &amp; therapeutics (Oxford)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chai, Edna Zhi Pei</au><au>Shanmugam, Muthu K</au><au>Arfuso, Frank</au><au>Dharmarajan, Arunasalam</au><au>Wang, Chao</au><au>Kumar, Alan Prem</au><au>Samy, Ramar Perumal</au><au>Lim, Lina H K</au><au>Wang, Lingzhi</au><au>Goh, Boon Cher</au><au>Ahn, Kwang Seok</au><au>Hui, Kam Man</au><au>Sethi, Gautam</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Targeting transcription factor STAT3 for cancer prevention and therapy</atitle><jtitle>Pharmacology &amp; therapeutics (Oxford)</jtitle><addtitle>Pharmacol Ther</addtitle><date>2016-06</date><risdate>2016</risdate><volume>162</volume><spage>86</spage><epage>97</epage><pages>86-97</pages><issn>0163-7258</issn><eissn>1879-016X</eissn><abstract>Signal Transducers and Activators of Transcription (STATs) comprise an important class of transcription factors that have been implicated in a wide variety of essential cellular functions related to proliferation, survival, and angiogenesis. Among various STAT members, STAT3 is frequently overexpressed in tumor cells as well as tissue samples, and regulates the expression of numerous oncogenic genes controlling the growth and metastasis of tumor cells. The current review briefly discusses the importance of STAT3 as a potential target for cancer therapy and also provides novel insights into various classes of existing pharmacological inhibitors of this transcription factor that can be potentially developed as anti-cancer drugs.</abstract><cop>England</cop><pmid>26478441</pmid><doi>10.1016/j.pharmthera.2015.10.004</doi><tpages>12</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0163-7258
ispartof Pharmacology & therapeutics (Oxford), 2016-06, Vol.162, p.86-97
issn 0163-7258
1879-016X
language eng
recordid cdi_proquest_miscellaneous_1793216340
source MEDLINE; Elsevier ScienceDirect Journals
subjects Animals
Antineoplastic Agents - pharmacology
Antineoplastic Agents - therapeutic use
Carcinogenesis - metabolism
Humans
Neoplasms - drug therapy
Neoplasms - metabolism
Neoplasms - prevention & control
Signal Transduction
STAT3 Transcription Factor - antagonists & inhibitors
STAT3 Transcription Factor - metabolism
title Targeting transcription factor STAT3 for cancer prevention and therapy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T10%3A09%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Targeting%20transcription%20factor%20STAT3%20for%20cancer%20prevention%20and%20therapy&rft.jtitle=Pharmacology%20&%20therapeutics%20(Oxford)&rft.au=Chai,%20Edna%20Zhi%20Pei&rft.date=2016-06&rft.volume=162&rft.spage=86&rft.epage=97&rft.pages=86-97&rft.issn=0163-7258&rft.eissn=1879-016X&rft_id=info:doi/10.1016/j.pharmthera.2015.10.004&rft_dat=%3Cproquest_cross%3E1793216340%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1793216340&rft_id=info:pmid/26478441&rfr_iscdi=true